|
Send Inquiry
+919016820285Contact Us For Help
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese
Ledipasvir and Sofosbuvir Tablets
Product Details:
- Dosage As Directed By Physician.
- Dosage Guidelines As Directed By Physician.
- Suitable For Adults
- Storage Instructions Store in a cool and dark place.
- Supply Ability : 1000000 Box Per Month
60 USD ($)
X
Price And Quantity
- As required by client. Box
- 60 USD ($)
Product Specifications
- As Directed By Physician.
- As Directed By Physician.
- Store in a cool and dark place.
- Adults
Trade Information
- Hazira / Nhava Sheva
- Telegraphic Transfer (T/T), Cash in Advance (CID), Cash Advance (CA)
- 1000000 Box Per Month
- 1-2 Week
- Yes
- If order is confirmed we will reimburse the sample cost
- Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
- WHO-GMP/ GMP/ COA/ As Required By Client
Product Description
Product Details:
| Brand | SOFOCRUZ LP |
We Salvavidas Pharmaceutical Pvt Ltd are a leading Manufacturer and Exporter of SOFOCRUZ LP TABLET (Sofosbuvir 400mg + Ledipasvir 90mg ) in different strength and packing. Our manufacturing facility is certified with WHO-GMP.
COMPOSITION :
SOFOCRUZ LP TABLET (Sofosbuvir 400mg + Ledipasvir 90mg )
- Brand name: SOFOCRUZ LP
- Active Ingredients(Generic Name) : Sofosbuvir 400mg + Ledipasvir 90mg
- Company Name: Torrent Pharmaceuticals Ltd
- Strength : 400 mg + 90 mg
- Package: 28 tabs
- Pack Type: Bottle
SOFOCRUZ LP Contain Sofosbuvir and Ledi pasvir For the treatment of Hepatitis C.
Hepatitis C is a liver disease caused by the hepatitis C virus the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.
- The hepatitis C virus is a blood borne virus and the most common modes of infection are through unsafe injection practices, inadequate sterilization of medical equipment, and the transfusion of unscreened blood and blood products.
- Globally, between 130-150 million people globally have chronic hepatitis C infection.
- A significant number of those who are chronically infected will develop liver cirrhosis or liver cancer.
- There is currently no vaccine for hepatitis C; however, research in this area is ongoing.
- injecting drug use through the sharing of injection equipment;
- the reuse or inadequate sterilization of medical equipment, especially syringes and needles in healthcare settings; and
- The transfusion of unscreened blood and blood products.
Treating chronic hepatitis C virus (HCV) infection in certain patients.
Ledipasvir and sofosbuvir is a combination of 2 hepatitis C virus (HCV) antiviral agents. It reduces the amount of HCV in the body by preventing the spread of the HCV within the body.
Available other Brand: HEPCINAT LP, LEDIFOS, RESOF L, LEDVICLEAR, MYHEP LVIR, HEPCVIR L, SOFOCURE L, NOVISOF L, LEDIHEP, SOFAB LP, LEDVICLEAR, SOFOKEM L, CIMIVIR
Other Products in 'Hepatitis C Medicine' category
Contact Details
- 803, Shubh Square, Near Lal Darwaja, Surat - 395004, Gujarat, India
- Corp. office :
#803, Shubh Square,Patelwadi-3, Near Lal Darwaja,Surat - 395004 (Gujarat) India. -
Send Inquiry
- Phone :+918037303586
- Mr Viral Dhaduk (Director)
- Mobile :918037303586
Send Inquiry
Send SMS
 |
SALVAVIDAS PHARMACEUTICAL PVT. LTD.
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Ltd. |